Thursday, October 4, 2012

Stellar Pharmaceuticals Launches New Migraine Treatment, CAMBIA(R), in $150 Million Canadian Prescription Migraine Market

...continued
   

URL: http://www.investorpoint.com/news/OTCBULLB/54781711/

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)